https://www.live-feeds.com/feed/doctors-absorb-the-stunning-failure-of-two-high-profile-heart-drugsContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/doctors-absorb-the-stunning-failure-of-two-high-profile-heart-drugshttps://www.live-feeds.com/feed/doctors-absorb-the-stunning-failure-of-two-high-profile-heart-drugs#u193916Wed, 11 Nov 2026 11:51:21 +0000Cardiologists are absorbing the stunning failure of two high-profile heart medications that failed to meet expectations in clinical trials. Novartis and Novo Nordisk saw trial failures for their promising treatments, leaving medical experts searching for answers. One medicine designed against an inherited heart risk and a promising cholesterol drug both failed to prevent expected health outcomes like heart attacks or stroke, upending previous confidence among researchers who considered the products strong bets.Why it mattersThese unexpected trial outcomes deal a significant blow to preventive